Antibiotic PK/PD in ICU clinical practice
Location: Palais des Congrès de Paris (2 Place de la Porte Maillot, 75017 Paris, France)
Dates: October 20, 2018 (during LIVES 2018 in Paris)
Master Class Directors:
Barbara Borgatta, United Kingdom; MD, PhD. Department of Intensive Care Medicine, Oxford University Hospitals NHS Foundation Trust; Chair of the Working Group on Antimicrobial Use, ESICM.
Jan De Waele, Belgium, MD, PhD, Professor, Department of Critical Care Medicine/ Surgical Intensive Care Unit, Ghent University Hospital, Belgium; Sr. Clinical Investigator – FWO – Research Foundation Flanders; Chair Infection (INF) Section, ESICM; Past-President, Belgian Society of Intensive Care Medicine
Endorsement: This Master Class is endorsed by the Infection Section, ESICM
For more information about registration, see the LIVES 2018 webpages.
Key Reasons to attend
- Get up-to-date on all aspects of empiric dose individualisation for antimicrobials, why antimicrobial PK is different in ICU patients, the importance of MIC for the need of antimicrobial dose adjustment and much more
- Participate in a highly interactive course
- Describe approaches for dose optimisation of antimicrobials
- Exchange best practice and network with leading experts and peers
- An application has been made to the UEMS EACCME® for CME accreditation of this event
- Importance of antimicrobial dosing
- Individualised dosing approaches
Who should attend this master class?
1. Doctors working in the ICU who want to learn about antimicrobial PK/PD and how to use it in every day clinical practice:
- Trainees in intensive care medicine, infectious diseases and internal medicine
- Senior intensivists and infectious diseases doctors wanting to improve and update their knowledge of antimicrobial therapy in the critically ill
2. Researchers and clinical pharmacists seeking to comprehend the clinical perspective of antimicrobial therapy in ICU
Social media: @ESICM #INF #infection #antibiotic